Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Eichhorst

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Best Practice & Research. Clinical Haematology|October 16, 2016
Current strategies to create tailored and risk-adapted therapies for CLL patientsPaula Cramer, Barbara Eichhorst, Hans Christian Reinhardt, et al.
Hemasphere|January 17, 2020
Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?Moritz Fürstenau, Nisha De Silva, Barbara Eichhorst, et al.
Leukemia|December 10, 2024
Surrogate endpoints in mature B-cell neoplasms - meaningful or misleading?Florian Simon, Othman Al-Sawaf, John F Seymour, et al.
Leukemia & Lymphoma|September 16, 2014
Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemiaValentin Goede, Barbara Eichhorst, Kirsten Fischer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2025
When and How Long to Treat Chronic Lymphocytic Leukemia?Carsten U Niemann, Abraham Varghese, Talha Munir, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Individualizing treatment decisions for older adults with hematologic malignanciesHeidi D Klepin, David Rizzieri, Antonio Palumbo, et al.
Leukemia & Lymphoma|September 18, 2015
Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study groupValentin Goede, Jasmin Bahlo, Viktoria Chataline, et al.
Future Oncology (London, England)|July 11, 2015
The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progressionPetra Langerbeins, Jasmin Bahlo, Christina Rhein, et al.
European Journal of Haematology|June 24, 2020
COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemiaPetra Langerbeins, Moritz Fürstenau, Henning Gruell, et al.
Haematologica|March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trialsValentin Goede, Paula Cramer, Raymonde Busch, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Best Practice & Research. Clinical Haematology|October 16, 2016
Current strategies to create tailored and risk-adapted therapies for CLL patientsPaula Cramer, Barbara Eichhorst, Hans Christian Reinhardt, et al.
Hemasphere|January 17, 2020
Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?Moritz Fürstenau, Nisha De Silva, Barbara Eichhorst, et al.
Leukemia|December 10, 2024
Surrogate endpoints in mature B-cell neoplasms - meaningful or misleading?Florian Simon, Othman Al-Sawaf, John F Seymour, et al.
Leukemia & Lymphoma|September 16, 2014
Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemiaValentin Goede, Barbara Eichhorst, Kirsten Fischer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2025
When and How Long to Treat Chronic Lymphocytic Leukemia?Carsten U Niemann, Abraham Varghese, Talha Munir, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Individualizing treatment decisions for older adults with hematologic malignanciesHeidi D Klepin, David Rizzieri, Antonio Palumbo, et al.
Leukemia & Lymphoma|September 18, 2015
Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study groupValentin Goede, Jasmin Bahlo, Viktoria Chataline, et al.
Future Oncology (London, England)|July 11, 2015
The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progressionPetra Langerbeins, Jasmin Bahlo, Christina Rhein, et al.
European Journal of Haematology|June 24, 2020
COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemiaPetra Langerbeins, Moritz Fürstenau, Henning Gruell, et al.
Haematologica|March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trialsValentin Goede, Paula Cramer, Raymonde Busch, et al.
Pageof 12